BLS Pharmaceuticals Limited (ASX:BLS)

BLS Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 12, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	240	213	89	10	38	8
Market Cap Growth	198.06%	140.05%	767.35%	-73.09%	395.11%	-57.14%
Enterprise Value	235	211	87	8	34	6
Last Close Price	1.01	0.93	0.41	0.05	0.20	0.12

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 12, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	15.15	13.84	18.11	-	-	-
PS Ratio	3.16	2.88	3.03	1.06	7.18	16.57
PB Ratio	7.52	6.85	7.33	3.10	2.53	-21.05
P/TBV Ratio	7.55	6.88	7.15	2.84	10.66	-
P/FCF Ratio	145.50	132.62	21.09	-	-	-
P/OCF Ratio	43.17	39.35	14.14	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 12, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	3.10	2.85	2.99	0.88	6.45	12.19
EV/EBITDA Ratio	10.99	10.47	10.91	-	-	-
EV/EBIT Ratio	11.71	10.79	11.33	-	-	-
EV/FCF Ratio	142.48	131.23	20.79	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 12, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.27	0.27	0.13	0.22	0.04	-1.09
Debt / EBITDA Ratio	0.40	0.40	0.18	-	-	-
Debt / FCF Ratio	5.25	5.25	0.36	-	-	-
Net Debt / Equity Ratio	-0.16	-0.16	-0.51	-0.10	-0.22	-0.91
Net Debt / EBITDA Ratio	-0.24	-0.24	-0.76	0.29	1.92	-0.78
Net Debt / FCF Ratio	-3.02	-3.02	-1.46	0.09	2.76	-0.58
Asset Turnover	2.06	2.06	2.23	0.79	0.58	0.30
Inventory Turnover	3.22	3.22	4.26	3.78	6.98	1.48
Quick Ratio	1.50	1.50	1.59	0.78	1.81	0.39
Current Ratio	2.90	2.90	2.46	1.92	2.25	0.49
Return on Equity (ROE)	71.30%	71.30%	63.64%	-141.75%	-26.18%	-62.97%
Return on Assets (ROA)	34.10%	34.10%	36.72%	-5.80%	-12.53%	-18.13%
Return on Capital Employed (ROCE)	51.60%	51.60%	58.60%	-29.90%	-12.10%	122.60%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 12, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	6.59%	7.23%	5.52%	-130.21%	-5.10%	-6.43%
FCF Yield	0.69%	0.75%	4.74%	-36.53%	-3.13%	-7.38%
Buyback Yield / Dilution	-6.91%	-6.91%	-11.36%	-43.61%	-83.52%	-14.42%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 11, 2026

Data Sources Report a data error